Asthma Drugs
-
{
- All
- News
-
Cipla, Pulmatrix Join Hands To Co-Develop Asthma Drug
As per the pact, Cipla Technologies will make an upfront payment of $22 million to Pulmatrix.
-
Asthma Drugs May Prevent A Deadly Form Of Pneumonia: Study
New York: Two drugs that are used to treat asthma and allergies may offer a way to prevent a form of pneumonia that can kill up to 40 per cent of people who contract it, researchers have found. Influenza pneumonia results when a flu infection spreads to alveolar air sacs deep within the lungs. Normally, a flu infection does not progress that far in...
-
Lupin To Market Novartis' Inhaler Under Loftair Brand Name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India.
-
Ajanta Pharma Launches Generic Asthma Drug in US Market
Ajanta Pharma on Monday said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market.
-
Cipla Recalls over 1.4 lakh Vials of Asthma Drug in US
As per the information available on the USFDA website, Cipla is recalling the drug for "failed impurities and degradation specifications".
-
Lupin Launches Asthma Drug Delivery Device in US
Lupin Pharmaceuticals Inc (LPI), a subsidiary of the company, has launched the all new InspiraChamber anti-static valved holding chamber (VHC) under a strategic licensing agreement with InspiRX Inc, the Mumbai-based firm said in a statement.
-
Scientific Review Finds Asthma Drugs Suppress Child Growth
Corticosteroid drugs given via inhalers to children with asthma may suppress their growth, according to two systematic reviews of scientific studies on the issue.
-
Glenmark Generics recalls anti-asthma drug from US market
Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to US Food and Drug Administration.
-
Exercise might aid asthma control
Adults whose asthma is not fully controlled by medication might gain some benefits from adding an exercise routine to their lives.
-
A new approach to asthma treatment
According to latest research drug size is the key to asthma treatment. Asthma inhalers could be made more effective if they used bigger drug particles. Researchers believe the finding could lead to less wasteful and more effective treatments for nearly 150 million people affected worldwide by this disease.
-
The fatal asthma drug trial resumed
A 24-year-old woman who died after taking part in a Johns Hopkins University asthma study was not fully informed of the risks involved. A committee has been formed to investigate the death as reported to the federal government's Office of Human Research Protection (OHRP). Hexamethonium, one of the drugs administered in the study, is not approved b...
-
Cipla, Pulmatrix Join Hands To Co-Develop Asthma Drug
As per the pact, Cipla Technologies will make an upfront payment of $22 million to Pulmatrix.
-
Asthma Drugs May Prevent A Deadly Form Of Pneumonia: Study
New York: Two drugs that are used to treat asthma and allergies may offer a way to prevent a form of pneumonia that can kill up to 40 per cent of people who contract it, researchers have found. Influenza pneumonia results when a flu infection spreads to alveolar air sacs deep within the lungs. Normally, a flu infection does not progress that far in...
-
Lupin To Market Novartis' Inhaler Under Loftair Brand Name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India.
-
Ajanta Pharma Launches Generic Asthma Drug in US Market
Ajanta Pharma on Monday said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market.
-
Cipla Recalls over 1.4 lakh Vials of Asthma Drug in US
As per the information available on the USFDA website, Cipla is recalling the drug for "failed impurities and degradation specifications".
-
Lupin Launches Asthma Drug Delivery Device in US
Lupin Pharmaceuticals Inc (LPI), a subsidiary of the company, has launched the all new InspiraChamber anti-static valved holding chamber (VHC) under a strategic licensing agreement with InspiRX Inc, the Mumbai-based firm said in a statement.
-
Scientific Review Finds Asthma Drugs Suppress Child Growth
Corticosteroid drugs given via inhalers to children with asthma may suppress their growth, according to two systematic reviews of scientific studies on the issue.
-
Glenmark Generics recalls anti-asthma drug from US market
Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to US Food and Drug Administration.
-
Exercise might aid asthma control
Adults whose asthma is not fully controlled by medication might gain some benefits from adding an exercise routine to their lives.
-
A new approach to asthma treatment
According to latest research drug size is the key to asthma treatment. Asthma inhalers could be made more effective if they used bigger drug particles. Researchers believe the finding could lead to less wasteful and more effective treatments for nearly 150 million people affected worldwide by this disease.
-
The fatal asthma drug trial resumed
A 24-year-old woman who died after taking part in a Johns Hopkins University asthma study was not fully informed of the risks involved. A committee has been formed to investigate the death as reported to the federal government's Office of Human Research Protection (OHRP). Hexamethonium, one of the drugs administered in the study, is not approved b...
